Clinical Trial Update: Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating amlexanox versus placebo in type 2 diabetes patients; results completed and posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Amlexanox (amlexanox)

Snippet

Sponsor: University of Michigan | Conditions: Diabetes Mellitus Type 2, Non-alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-05-09